Corbus Pharmaceuticals Holdings, Inc.
CRBP
$10.09
$0.010.10%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 117.94M | 138.22M | 163.27M | 103.98M | 116.59M |
| Total Receivables | 1.50M | 1.50M | 1.50M | -- | 1.50M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 3.31M | 3.46M | 1.52M | 3.30M | 4.45M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 385.00K | 670.00K | 285.00K | 285.00K |
| Total Current Assets | 122.75M | 143.57M | 166.95M | 107.57M | 122.83M |
|
|
|||||
| Total Current Assets | 122.75M | 143.57M | 166.95M | 107.57M | 122.83M |
| Net Property, Plant & Equipment | 3.85M | 914.00K | 1.24M | 1.56M | 1.88M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 385.00K | -- | -- | 385.00K | 385.00K |
| Total Assets | 126.99M | 144.48M | 168.20M | 109.51M | 125.09M |
|
|
|||||
| Total Accounts Payable | 5.25M | 435.00K | 2.22M | 2.74M | 3.99M |
| Total Accrued Expenses | 15.23M | 16.50M | 16.84M | 12.58M | 7.65M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 999.00K | 1.21M | 1.63M | 1.74M | 1.70M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 21.48M | 18.14M | 20.69M | 17.06M | 13.33M |
|
|
|||||
| Total Current Liabilities | 21.48M | 18.14M | 20.69M | 17.06M | 13.33M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 3.27M | -- | -- | 307.00K | 761.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.75M | 18.14M | 20.69M | 17.37M | 14.09M |
|
|
|||||
| Common Stock & APIC | 715.78M | 704.90M | 702.99M | 627.03M | 622.56M |
| Retained Earnings | -613.44M | -578.40M | -555.43M | -534.88M | -511.53M |
| Treasury Stock & Other | -107.00K | -161.00K | -53.00K | -3.00K | -39.00K |
| Total Common Equity | 102.24M | 126.34M | 147.50M | 92.15M | 110.99M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 102.24M | 126.34M | 147.50M | 92.15M | 110.99M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 102.24M | 126.34M | 147.50M | 92.15M | 110.99M |
|
|
|||||